COMP <GO>
IDCC vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
InterDigital Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: IDCC 9
— TMO 4
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: IDCC
LAST: $311.57 (-6.79%) • MKT CAP: $8.63B
balance-sheet
8.32
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IDCC VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IDCC | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 52.80% | 9.30% | +43.50 | IDCC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.7x | 30.4x | -13.70 | IDCC | /valuation <GO> |
| Free Cash Flow Yield | 6.13% | 2.40% | +3.73 | IDCC | /fcf-yield <GO> |
| Operating Margin | 55.30% | 17.40% | +37.90 | IDCC | /operating-margins <GO> |
| Net Profit Margin | 48.80% | 15.10% | +33.70 | IDCC | /net-margins <GO> |
| Revenue Growth (YoY) | -4.00% | 3.90% | -7.90 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.70% | 0.24% | +0.46 | IDCC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 8.32 | 4.50 | +3.82 | IDCC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.70% | -0.20 | IDCC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.0 | 59.1 | -18.13 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.94 | -0.07 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.7x | 36.3x | -16.60 | IDCC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.63B | $262.22B | -$253.59B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IDCC REV | TMO REV | IDCC GROSS % | TMO GROSS % | IDCC FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $834.0M | $44.56B | 44.0% | 44.0% | $528.6M | $6.29B |
| FY 2024 | $868.5M | $42.88B | 44.0% | 44.0% | $265.7M | $7.27B |
| FY 2023 | $549.6M | $42.86B | 44.0% | 44.0% | $189.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IDCC // BETA 0.87
TMO // BETA 0.94